The transient knockdown of IGFBP1 significantly restored the cellular sensitivity towards RG7388 indicated that IGFBP1 is one of the most promising candidates that can be targeted to overcome drug resistance in glioma [95]. The gene discussed is IGFBP1; the disease is glioma.